Effective July 30, 2013, Maria Peralta resigned as a director and officer Okana Ventures Inc. and Richard Azani and Patrick Charles Frankham were appointed directors of the company. Also effective July 30, 2013, Richard Azani was appointed as its president, secretary, chief financial officer and treasurer of the company. Since March 30, 2011, Mr. Azani has been a director of Neurokine Pharmaceuticals Inc. Mr. Azani has been the president, chief executive officer, chief financial officer and director of A5 Laboratories Inc. Prior to joining Boehringer Ingelheim, Patrick Charles Frankham founded several multinational healthcare startup enterprises including healthcare information technology, services and pharmaceuticals companies.